OrbiMed Genesis GP LLC is 10% Owner at Galecto, Inc. (GLTO). They have made 14 open-market trades across 10 companies since 2021, most recently 2026-09-28.
CIK 0001808744
7 open-market purchases totalling $39.2M since 2021, against 7 sales. Across 6 scored buys the stock is down 6.8% at ninety days, and 9.6 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 33% | 50% |
| Avg Move | -5.1% | -5.2% | -6.8% |
| Alpha | -5.5% | -6.8% | -9.6% |
| Scored | 7 | 6 | 6 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 29% | 43% |
| Avg Move | +0.5% | +7.1% | +13.2% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADRX | BUY | 2026-09-28 | 2026-09-30 | $17.00 | $16.1M | -10.7% | — | — |
| EWTX | BUY | 2025-04-03 | 2025-04-04 | $20.13 | $10.0M | +11.7% | +41.9% | +11.7% |
| MBX | BUY | 2025-02-14 | 2025-02-19 | $10.59 | $710K | -13.3% | -32.5% | +5.7% |
| TERN | SELL | 2024-07-16 | 2024-07-17 | $10.00 | $52K | -12.8% | -24.1% | -20.4% |
| ALPN | SELL | 2023-12-27 | 2023-12-29 | $18.54 | $28.7M | +4.5% | +38.8% | +110.7% |
| IRON | SELL | 2023-12-18 | 2023-12-20 | $59.24 | $102K | +3.3% | +12.4% | +17.5% |
| IRON | SELL | 2023-12-14 | 2023-12-14 | $57.73 | $6K | -1.3% | +6.5% | +11.6% |
| PMVP | SELL | 2023-11-22 | 2023-11-24 | $2.23 | $392K | +3.5% | +35.7% | -23.8% |
| GLTO | SELL | 2023-04-05 | 2023-04-07 | $2.17 | $414K | +7.6% | +6.3% | +29.7% |
| TERN | BUY | 2022-12-23 | 2022-12-28 | $7.25 | $1000K | -4.6% | -14.5% | +15.6% |
| EWTX | BUY | 2022-09-16 | 2022-09-16 | $10.32 | $5.0M | +9.1% | +0.8% | -20.8% |
| PMVP | SELL | 2022-03-29 | 2022-03-31 | $21.60 | $11.0M | -1.4% | -25.5% | -33.0% |
| KNTE | BUY | 2022-02-15 | 2022-02-15 | $9.96 | $90K | -25.6% | -1.9% | -3.4% |
| CMPX | BUY | 2021-11-04 | 2021-11-08 | $3.50 | $6.3M | -2.0% | -24.8% | -49.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ELVN | 288,114 | $10.8M |
| ADRX | 588,235 | $10.3M |
| GLTO | 186,613 | $5.4M |
| JANX | 231,098 | $3.8M |
| KNTE | 550,000 | $1.5M |
| KROS | 45,057 | $481K |
| IKNA | 157,288 | $225K |
| PMVP | 34,500 | $42K |
| Total | $1.2B |
Shares reported on the most recent Form 4, priced at the 2026-09-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 7 | 7 | 7 |